This is a $19,656.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Revvity Health Sciences, Inc. for the delivery of thymidine triphosphate. The award does not have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has previously received prime contracts, subcontracts, and indefinite delivery vehicles (IDVs)...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Revvity Health Sciences, Inc. for the supply of a Perkin Elmer brand-name product. The $125,670.00 contract has a period of performance from August 1, 2019 to July 31, 2020 and does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that provides medical imaging products...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,670.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the STEADYLITE PLUS 1000ML KIT. The contract, which does not have a set-aside designation, was awarded on August 1, 2019 with a completion date of August 23, 2019. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. for $5,472.00. The contract is for the provision of medical imaging products and services, with a period of performance from September 15, 2017 to September 17, 2018. This contract was not set aside for any small business category. Revvity Health Sciences, Inc. is a for-profit...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is valued at $10,652.49 and has a period of performance from April 24, 2024 to April 23, 2025. The contract does not have a set-aside designation. Revvity Health Sciences has a history of providing a variety...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The $24,821.53 contract has an ultimate completion date of October 13, 2024. It does not appear to have been set aside for any specific business type. Revvity Health Sciences has a history of providing a variety of medical devices and equipment, including automated plate readers, imaging...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Revvity Health Sciences, Inc. for the delivery of analytical development consumable supplies to support the Vaccine Production Program's therapeutic and vaccine candidates. The $128,403.24 contract includes protein reagents, DNA/RNA labchips, and shipping for four deliveries between July 2024 and April 2025. This procurement was competed as a Request for Quotes (RFQ) under Simplified...
This is a $139,310.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The contract is for the delivery of 6066769 BRITELITE PLUS 100 ML KIT medical imaging products. It does not have a small business set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging and laboratory...